Biovitrum proposes rights offering

Biovitrum AB (SSE:BVT), Stockholm, Sweden Business: Hematology, Endocrine, Neurology Date announced: 12/2/09 Type: Rights offering To be raised: Up to SEK1.5 billion ($213.6 million) Shares: 100.8 mil...